Indication

Erythrasma

Erythrasma is a common, chronic, superficial bacterial infection of the integumentary system primarily caused by *Corynebacterium minutissimum*, a normal cutaneous commensal. Read more about Erythrasma

53 drugs 26 manufacturers

Advertisement

Drugs that treat it

Common Erythrasma therapies.

Showing 19–27 of 53 drugs

Filter & compare in the drug finder →Opens the drug finder with Erythrasma preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Erythrasma.

Erythrasma is a common, chronic, superficial bacterial infection of the integumentary system primarily caused by *Corynebacterium minutissimum*, a normal cutaneous commensal.

The condition predominantly affects adults and manifests in warm, moist, intertriginous areas—most frequently the axillary, inguinal, inframammary, and interdigital spaces.

Pathophysiologically, the organism proliferates within the stratum corneum under humid or occlusive conditions, producing sharply demarcated, reddish-brown to violaceous macules and plaques with fine scaling.

A hallmark clinical feature is the production of coproporphyrin III by the proliferating bacteria, which elicits a characteristic coral-red fluorescence under Wood’s lamp examination.

Personalize your experience

Follow Erythrasma and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it